Published on September 4, 2010 at 12:02 AM
Revolutions Medical ("Revolutions Medical" or the "Company") (OTCBB:RMCP) signs Letter of Intent today with Medical Investment Group, LLC for the Manufacturing of the RevVac Safety Syringe. The final terms are expected to be completed in definitive documents between the parties no later than September 17th, 2010.
The agreed upon general terms provide for the manufacturing of 5 million syringes per month and can allow an increase of up to 20 million syringes per month. MIG has both domestic and international manufacturing capabilities.
SOURCE Revolutions Medical Corporation